Venus Concept shares surge 18.11% premarket after receiving 510(k) clearance for Venus Versa Pro multi-application platform.

Venus Concept (NASDAQ:VERO) surged 18.11% in premarket trading, likely driven by renewed investor confidence following the company’s September 14 announcement of 510(k) clearance for its Venus Versa Pro multi-application platform. This regulatory approval validates the product’s market readiness, enhancing its commercial potential in aesthetic treatments. Additionally, short interest in VERO dropped by 19.6% on September 16, indicating reduced bearish pressure and potential short-covering activity. These developments align with the stock’s sharp premarket rally, as positive regulatory progress and reduced short-term pessimism typically attract buying interest. Earlier updates, such as the July 13 medical advisory board formation for AI.ME™ and the March 20 ARTAS iX launch, provided foundational credibility but were less immediately impactful.